JP2004513369A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004513369A5 JP2004513369A5 JP2002541398A JP2002541398A JP2004513369A5 JP 2004513369 A5 JP2004513369 A5 JP 2004513369A5 JP 2002541398 A JP2002541398 A JP 2002541398A JP 2002541398 A JP2002541398 A JP 2002541398A JP 2004513369 A5 JP2004513369 A5 JP 2004513369A5
- Authority
- JP
- Japan
- Prior art keywords
- platelet
- blood
- edta
- ctad
- platelets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0027309.4A GB0027309D0 (en) | 2000-11-08 | 2000-11-08 | Method of measuring measuring platlet activation |
| PCT/GB2001/004946 WO2002039124A1 (en) | 2000-11-08 | 2001-11-08 | Method of measuring platelet activation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004513369A JP2004513369A (ja) | 2004-04-30 |
| JP2004513369A5 true JP2004513369A5 (enExample) | 2005-04-28 |
Family
ID=9902807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002541398A Pending JP2004513369A (ja) | 2000-11-08 | 2001-11-08 | 血小板活性の測定方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7011938B2 (enExample) |
| EP (1) | EP1332373B1 (enExample) |
| JP (1) | JP2004513369A (enExample) |
| AT (1) | ATE522808T1 (enExample) |
| AU (2) | AU2002212529B2 (enExample) |
| CA (1) | CA2428224C (enExample) |
| ES (1) | ES2372810T3 (enExample) |
| GB (1) | GB0027309D0 (enExample) |
| WO (1) | WO2002039124A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2392724A (en) * | 2002-09-06 | 2004-03-10 | Ian Stoakes | Methods of and apparatus for blood analysis |
| US7723064B2 (en) * | 2004-07-26 | 2010-05-25 | Siemens Healthcare Diagnostics Inc. | Methods for monitoring patients for efficacy of an antiplatelet therapy regimen |
| US7811549B2 (en) * | 2006-07-05 | 2010-10-12 | Adenobio N.V. | Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects |
| US8021854B2 (en) * | 2007-10-05 | 2011-09-20 | Attila Mady | Method of treating vascular disease |
| US8835104B2 (en) | 2007-12-20 | 2014-09-16 | Fenwal, Inc. | Medium and methods for the storage of platelets |
| WO2009092516A2 (en) * | 2008-01-22 | 2009-07-30 | Adenobio N.V. | Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects |
| US10575515B2 (en) | 2010-05-04 | 2020-03-03 | The General Hospital Corporation | Methods and compositions for preserving tissues and organs |
| EP3662750A1 (en) | 2011-04-07 | 2020-06-10 | Fenwal, Inc. | Automated methods and systems for providing platelet concentrates with reduced residual plasma volumes and storage media for such platelet concentrates |
| DK3054936T5 (da) | 2013-10-10 | 2024-03-18 | Eastern Virginia Medical School | 4-((2-hydroxy-3-methoxybenzyl)amino) benzensulfonamid derivater som 12-lipoxygenase inhibitorer |
| JP6687601B2 (ja) | 2014-08-07 | 2020-04-22 | ザ ジェネラル ホスピタル コーポレイション | 全血サンプルの安定化 |
| US10908171B2 (en) | 2016-07-12 | 2021-02-02 | EMULATE, Inc. | Additive channels |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08220094A (ja) * | 1995-02-08 | 1996-08-30 | Dai Ichi Pure Chem Co Ltd | 血漿中ｇｍｐ−１４０の測定法 |
| FR2731277A1 (fr) * | 1995-03-02 | 1996-09-06 | Benveniste Jacques | Procedes et appareil pour faciliter la purification, le comptage et la mesure de l'activation des leucocytes sanguins |
| US5817519A (en) * | 1995-12-28 | 1998-10-06 | Bayer Corporation | Automated method and device for identifying and quantifying platelets and for determining platelet activation state using whole blood samples |
| US6309888B1 (en) * | 1998-09-04 | 2001-10-30 | Leuven Research & Development Vzw | Detection and determination of the stages of coronary artery disease |
-
2000
- 2000-11-08 GB GBGB0027309.4A patent/GB0027309D0/en not_active Ceased
-
2001
- 2001-11-08 ES ES01980741T patent/ES2372810T3/es not_active Expired - Lifetime
- 2001-11-08 US US10/415,336 patent/US7011938B2/en not_active Expired - Fee Related
- 2001-11-08 AU AU2002212529A patent/AU2002212529B2/en not_active Ceased
- 2001-11-08 CA CA2428224A patent/CA2428224C/en not_active Expired - Fee Related
- 2001-11-08 WO PCT/GB2001/004946 patent/WO2002039124A1/en not_active Ceased
- 2001-11-08 AU AU1252902A patent/AU1252902A/xx active Pending
- 2001-11-08 JP JP2002541398A patent/JP2004513369A/ja active Pending
- 2001-11-08 AT AT01980741T patent/ATE522808T1/de not_active IP Right Cessation
- 2001-11-08 EP EP01980741A patent/EP1332373B1/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Macey et al. | Use of mean platelet component to measure platelet activation on the ADVIA 120 haematology system | |
| Harris et al. | The ADVIA 2120 hematology system: flow cytometry-based analysis of blood and body fluids in the routine hematology laboratory | |
| US6664110B1 (en) | Erythroblast diagnostic flow-cytometry method and reagents | |
| Lyberg | Blood platelet activation evaluated by flow cytometry: optimised methods for clinical studies | |
| Buttarello et al. | Automated blood cell counts: state of the art | |
| US5858790A (en) | Hematology reference control and method of preparation | |
| AU669692B2 (en) | Suspension media for hematological composition and method for its use | |
| JP2557837B2 (ja) | 白血球の３つの母集団についての血液学規準コントロール流体懸濁物およびその製造方法 | |
| US6524858B1 (en) | Single channel, single dilution detection method for the identification and quantification of blood cells and platelets in a whole blood sample using an automated hematology analyzer | |
| JP3704654B2 (ja) | 全血サンプルを使用して血小板を同定および定量し、血小板の活性化状態を測定する高感度で正確かつ精密な自動化方法 | |
| Ahnadi et al. | Assessment of platelet activation in several different anticoagulants by the Advia 120 Hematology System, fluorescence flow cytometry, and electron microscopy | |
| US5786224A (en) | Reagent and method for differential determination of leukocytes in blood | |
| EP0846264B1 (en) | Reagent and method for differential determination of leukocytes in blood | |
| Riley et al. | Reticulocyte analysis by flow cytometry and other techniques | |
| EP1766045B1 (en) | Hematology reference control containing an immature granulocyte component | |
| Chapman et al. | A rapid, automated flow cytometric method to measure activated degranulated platelets by density determination | |
| US7449337B2 (en) | Lytic reagent and method for leukocytes differential in whole blood | |
| JP2004513369A5 (enExample) | ||
| EP1332373B1 (en) | Method of measuring leucocyte activation | |
| AU2002212529A1 (en) | Method of measuring platelet activation | |
| EP2291652B1 (en) | Stabilisation of blood cell conjugates | |
| US6852534B2 (en) | Method to determine an engrafting cell dose of hematopoietic stem cell transplant units | |
| Nemec et al. | The effect of high anticoagulant k3-edta concentration on complete blood count and white blood cell differential counts in healthy beagle dogs | |
| Solanki et al. | Spurious red blood cell parameters due to serum cold agglutinins: Observations on Ortho ELT-8® Cell Counter | |
| Ratnaningsih et al. | The effects of excessive disodium ethylene diamine tetraacetic acid (Na 2 EDTA) anticoagulant concentration toward hematology profile and morphology of erythrocytes in peripheral blood examination |